The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115151109 11515110 9 F 20150826 20160901 20150916 20160909 EXP JP-GILEAD-2015-0170898 GILEAD 67.00 YR E F Y 156.00000 KG 20160909 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115151109 11515110 1 PS SOVALDI SOFOSBUVIR 1 Oral 400 MG, QD 6000 MG 204671 400 MG TABLET QD
115151109 11515110 2 SS REBETOL RIBAVIRIN 1 Oral 200 MG AM, 400 MG PM 0 CAPSULE BID
115151109 11515110 3 SS HALFDIGOXIN DIGOXIN 1 Oral 0.125 MG, QD 46 MG 0 .125 MG TABLET QD
115151109 11515110 4 C DIART AZOSEMIDE 1 Oral 45 MG, QD 3825 MG 0 45 MG TABLET QD
115151109 11515110 5 C MUCOSAL /00082801/ 2 Oral 45 MG, QD 4590 MG 0 15 MG TABLET TID
115151109 11515110 6 C URSO URSODIOL 1 Oral 600 MG, QD 0 200 MG TABLET TID
115151109 11515110 7 C MAINTATE BISOPROLOL FUMARATE 1 Oral 1.250 MG, QD 0 .625 MG TABLET BID
115151109 11515110 8 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 20 MG, QD 3660 MG 0 20 MG CAPSULE QD
115151109 11515110 9 C SINGULAIR MONTELUKAST SODIUM 1 Oral 10 MG, QD 970 MG 0 10 MG TABLET QD
115151109 11515110 10 C WARFARIN /00014802/ WARFARIN 1 Oral 2 MG, QD 0 2 MG TABLET QD
115151109 11515110 11 C AMBROXOL AMBROXOL 1 Unknown 45 MG, QD 0 45 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115151109 11515110 1 Hepatic cirrhosis
115151109 11515110 2 Hepatic cirrhosis
115151109 11515110 3 Atrial fibrillation
115151109 11515110 4 Right ventricular failure
115151109 11515110 5 Asthma
115151109 11515110 6 Hepatitis C
115151109 11515110 7 Atrial fibrillation
115151109 11515110 8 Gastrooesophageal reflux disease
115151109 11515110 9 Asthma
115151109 11515110 10 Atrial fibrillation

Outcome of event

Event ID CASEID OUTC COD
115151109 11515110 DE
115151109 11515110 OT
115151109 11515110 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
115151109 11515110 Arthralgia
115151109 11515110 Diarrhoea
115151109 11515110 Hyperbilirubinaemia
115151109 11515110 Hypokalaemia
115151109 11515110 Inflammation
115151109 11515110 Malaise
115151109 11515110 Meniscus injury
115151109 11515110 Pyrexia
115151109 11515110 Torsade de pointes
115151109 11515110 Urinary tract infection
115151109 11515110 Ventricular fibrillation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
115151109 11515110 1 20150818 20150902 0
115151109 11515110 2 20150818 20150902 0
115151109 11515110 3 20140728 20150902 0
115151109 11515110 4 20150609 20150902 0
115151109 11515110 5 20150523 20150902 0
115151109 11515110 6 2009 20150902 0
115151109 11515110 7 2009 20150902 0
115151109 11515110 8 20150303 20150902 0
115151109 11515110 9 20150528 20150902 0
115151109 11515110 10 2009 20150902 0
115151109 11515110 11 20150902 0